Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Clene Inc. is a clinical-stage pharmaceutical company developing innovative nanotechnology-based therapeutics targeting neurodegenerative and infectious diseases. Its proprietary clean-surfaced nanocrystals support cellular energy, reduce oxidative stress, and address protein aggregation. Focused on CNS disorders like ALS, MS, and Parkinson’s, the company aims to revolutionize treatment through catalytically active nanocrystals with broad applicability and multi-modal mechanisms of action.
This description was generated via AI from an annual report. Updated about 1 year ago.